Drug Discovery
AI platforms accelerating target identification, molecular design, and hit-to-lead optimization for small molecules and biologics.
AI Vendors in this Category
Related Business Problems
- Biomedical data is growing faster than teams can read it
- Developability problems surface too late
- Identifying novel, validated drug targets is hard
- Lead optimization cycles are too slow
- New uses for existing drugs are going unnoticed
- Screening produces too many low-quality hits
- Too many candidates fail late on ADMET and toxicity